Ignite Creation Date:
2024-05-05 @ 6:35 PM
Last Modification Date:
2024-10-26 @ 9:34 AM
Study NCT ID:
NCT00508001
Status:
COMPLETED
Last Update Posted:
2016-10-10
First Post:
2007-07-25
Brief Title:
Phase II Study of Best Support Care BSC Plus ZD6474Vandetanib in Patients With Inoperable Hepatocellular Carcinoma HCC
Sponsor:
Genzyme a Sanofi Company
Organization:
Sanofi
Key Dates - Follows AllAPIJSON File Order
Start Date:
2007-07
Start Date Type:
None
Primary Completion Date:
2008-11
Primary Completion Date Type:
ACTUAL
Completion Date:
2009-06
Completion Date Type:
ACTUAL
First Submit Date:
2007-07-25
First Submit QC Date:
July 26 2007
Study First Post Date:
2007-07-27
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2012-07-17
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2016-08-29
Last Update Post Date:
2016-10-10
Last Update Post Date Type:
ESTIMATED